Summary of the Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults

Overview

Journal J Am Acad Child Adolesc Psychiatry

Publisher Elsevier

Specialties Pediatrics
Psychiatry

Date 2001 Nov 9

PMID 11699811

Citations 18

Authors

L L Greenhill

S Pliszka

M K Dulcan

W Bernet

V Arnold

J Beitchman

R S Benson

O Bukstein

J Kinlan

J McClellan

D Rue

J A Shaw

S Stock

K Kroeger

Affiliations

Soon will be listed here.

Abstract

This practice parameter describes treatment with stimulant medication. It uses an evidence-based medicine approach derived from a detailed literature review and expert consultation. Stimulant medications in clinical use include methylphenidate, dextroamphetamine, mixed salts of amphetamine, and pemoline. They carry U.S. Food and Drug Administration indications for the treatment of attention-deficit hyperactivity disorder.

Citing Articles

A randomized, double-blind, cross-over, phase IV trial of oros-methylphenidate (CONCERTA(®)) and generic novo-methylphenidate ER-C (NOVO-generic).

Fallu A, Dabouz F, Furtado M, Anand L, Katzman M Ther Adv Psychopharmacol. 2016; 6(4):237-51.

PMID: 27536342 PMC: 4971598. DOI: 10.1177/2045125316643674.

Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD.

Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin S Drug Des Devel Ther. 2014; 8:1685-93.

PMID: 25336914 PMC: 4199984. DOI: 10.2147/DDDT.S68393.

Steady-state bioavailability of extended-release methylphenidate (MPH-MLR) capsule vs. immediate-release methylphenidate tablets in healthy adult volunteers.

Adjei A, Kupper R, Teuscher N, Wigal S, Sallee F, Childress A Clin Drug Investig. 2014; 34(11):795-805.

PMID: 25274428 DOI: 10.1007/s40261-014-0234-x.

Exploring stimulant treatment in ADHD: narratives of young adolescents and their parents.

Charach A, Yeung E, Volpe T, Goodale T, dosReis S BMC Psychiatry. 2014; 14:110.

PMID: 24725829 PMC: 3996107. DOI: 10.1186/1471-244X-14-110.

Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA study.

Valdizan-Uson J, Canovas-Martinez A, De Lucas-Taracena M, Diaz-Atienza F, Eddy-Ives L, Fernandez-Jaen A Neuropsychiatr Dis Treat. 2013; 9:211-8.

PMID: 23430373 PMC: 3573811. DOI: 10.2147/NDT.S35836.